• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Long-Term Outcomes in Anxiety Treatment

Long-Term Outcomes in Anxiety Treatment

February 1, 2014
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Subject:
Anxiety

Short Description:

Long-Term Outcomes in Anxiety Treatment

Background:

Anxiety disorders are among the most common psychiatric conditions in kids, and they are often predictive of future psychiatric problems. Researchers recently examined if effective treatment of anxiety disorders early on had positive long-term outcomes.

In this naturalistic follow-up study (known as CAMELS), researchers looked at a group of 288 youths (mean age 17 years) who were originally enrolled in the Child/Adolescent Anxiety Multimodal Study (CAMS) to evaluate how they fared years after treatment for anxiety disorders. The children in CAMS had primary diagnoses of social, separation, or generalized anxiety disorder. They were randomized to 12 weeks of either: cognitive behavioral therapy (CBT); medication (sertraline); combined treatment; or pill placebo.

Participants (59% of the original CAMS sample) were followed up with, on average, six years later. They were assessed for presence and/or severity of anxiety disorders. Almost half (46.5%) of the sample were in remission at follow-up. Remission rates did not vary greatly based on treatment. Among the 53.3% of children who were not in remission, close to half of them (46.8%) also had a comorbid internalizing disorder and 27.3% had an externalizing disorder (compared to just 10.4% and 9.7%, respectively, in the remission group).

While the children in the remission group were much more likely to have been responders to treatment in the original study, close to half (48%) of acute responders in CAM had relapsed at follow-up. Male sex, higher socio-economic status (SES), and better family functioning predicted better outcomes, as did lower baseline anxiety scores (Ginsburg GS et al, JAMA Psychiatry 2014;online ahead of print).

CCPR’s Take: It’s great to hear that after six years, close to half of the children with anxiety disorders in the original study had no diagnosable anxiety disorders at follow-up. However, close to 50% of the kids who responded to treatment had relapsed by six years later. Almost 70% of CAM participants who were evaluated at follow-up had received some additional treatment in the interim (medication, therapy, or both). These youths were less likely to be in remission. Other predictors of poor outcome include externalizing disorders at baseline and higher baseline anxiety scores. Considering that higher SES and better family functioning were among the main predictive factors for long-term remission, more focus on parenting, environmental stressors, and family therapy could lead to better long-term outcomes.

Child Psychiatry
KEYWORDS anxiety disorders anxiety_disorder child-psychiatry
    www.thecarlatreport.com
    Issue Date: February 1, 2014
    SUBSCRIBE NOW
    Table Of Contents
    Missing the Forest for the Trees: How to Treat Children With Nonverbal Learning Disability
    Brain Development Effects of Prenatal Exposure to Drugs and Alcohol
    Working With Schools and Children With Learning Disabilities
    Long-Term Outcomes in Anxiety Treatment
    Treating Autism Costs $17K More Per Child Each Year
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.